Identification and Clinical Characterization of a Novel Alpha-Galactosidase A Mutation

AUTOR(ES)

Rosa Neto, Nilton Salles

FONTE

J. inborn errors metab. screen.

DATA DE PUBLICAÇÃO

15/07/2019

RESUMO

Abstract Fabry disease (FD) is an inborn error of metabolism characterized by deficient/absent activity of lysosomal enzyme alpha-galactosidase A, which results in systemic accumulation of glycosphingolipids and progression to renal failure, heart and cerebrovascular disease, and small-fiber peripheral neuropathy. This article describes a Brazilian family affected by FD caused by a novel mutation in exon 6 of the alpha-galactosidase A (GLA) gene (c.812G>C). Signs and symptoms identified were pain crisis, acroparesthesia, hypohidrosis, abdominal cramps and diarrhea, chronic kidney disease, cornea verticillata, left ventricular hypertrophy, and complete heart block. Headache was a common complaint and 1 of the patients presented with aseptic meningitis. The novel missense mutation in the GLA gene identified in this Brazilian family is consistent with the classic FD phenotype.

Documentos Relacionados

• Purification and characterization of an alpha-galactosidase from Aspergillus fumigatus
• Purification and characterization of thermostable beta-mannanase and alpha-galactosidase from Bacillus stearothermophilus.
• Nucleotide sequence of the human alpha-galactosidase A gene.
• Alpha-galactosidase production and use in a hollow-fiber reactor.
• Sequence variations in the first exon of alpha-galactosidase A.